[1]
E. Budak and A. Yanarates, “The role of PET/CT in determining egfr mutation and ALK rearrangement in patients with lung adenocarcinoma ”, Ann Med Res , vol. 27, no. 2, pp. 0634–0640, May 2021, Accessed: Sep. 16, 2026. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/607